Mylan issues nationwide recall of EpiPens due to possible defect

FILE - In this July 8, 2016 file photo, a package of EpiPens, an epinephrine autoinjector for the treatment of allergic reactions is displayed in Sacramento, Calif. Lawmakers are demanding more information on why the price for live-saving EpiPens has skyrocketed. EpiPens are used largely by children to ward off potentially fatal allergic reactions, and its price has surged in recent years. A two-dose package cost less than $60 nine years ago. The cost is now closer to $400. (AP Photo/Rich Pedroncelli, File)

Meridian Medical Technologies, the company who manufactures Mylan's EpiPen injector, has issued a voluntary, nationwide recall of its EpiPen and EpiPen Jr.

According to the company, some of the devices possibly have a defective part that doesn't allow for the activation of the injector in case of allergic reaction. The company said the number of reported failures was "small," but they decided to pull the products for fear of a life-threatening risk if a severe allergic reaction went untreated as a result.

The recall affects 13 lots of EpiPen and EpiPen Jr. devices distributed between Dec. 17, 2015, and July 1, 2016.

Any of the affected devices will be replaced by Mylan for free.

Customers are advised keep and use their EpiPens, if needed, until their replacements are received

Those with questions should contact Mylan at 800-796-9526 or

close video ad
Unmutetoggle ad audio on off